MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, announced that Proteologix US Inc. has been selected as the North American winner of its 12th Advance Biotech Grant program. The biotechnology start-up, which is headquartered in Redwood City, CA, was selected for its robust pipeline targeting autoimmune/inflammatory diseases and oncology indications that affect a large patient population. As part of the award, Proteologix will receive in-kind product...